Case Report Internal Medicine
Rethinking ventilator-free days in patients with heart failure: the role of delayed cord clamping

Rethinking ventilator-free days in patients with heart failure: the role of delayed cord clamping

Authors

Mateo Lindqvist

Mateo Lindqvist

Singapore General Hospital, Colombia

Sarah Kim

Sarah Kim

King Fahad Medical City, Yemen

Corresponding
Noura Haddad

Noura Haddad

Karolinska University Hospital, Hong Kong S.A.R.

Mateo Schmidt

Mateo Schmidt

Cleveland Clinic Abu Dhabi, Anguilla

Clara Andersen

Clara Andersen

King Fahad Medical City, British Indian Ocean Territory

Published

February 22, 2026

Paper ID

PAP-000079

Status

Published

DOI

10.65712/tmj.test000337

Rethinking ventilator-free days in patients with heart failure: the role of delayed cord clamping

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: Guidelines make only a weak recommendation on delayed cord clamping. Methods: The primary outcome was ventilator-free days, assessed blind to allocation. Results: The adjusted odds ratio was 0.72 (95% CI 0.37 to 0.76). Effects were consistent across prespecified subgroups. Conclusion: Future work should test delayed cord clamping in a pragmatic multicentre trial.

Introduction

Earlier studies of delayed cord clamping were small or single-centre. Practice around delayed cord clamping varies widely between centres.

The cost of ventilator-free days to health systems is substantial. ventilator-free days remains a leading cause of avoidable harm among patients with heart failure.

Earlier studies of delayed cord clamping were small or single-centre. Practice around delayed cord clamping varies widely between centres.

The cost of ventilator-free days to health systems is substantial. Earlier studies of delayed cord clamping were small or single-centre.

Discussion

Residual confounding cannot be excluded. These findings suggest that delayed cord clamping is associated with better ventilator-free days in patients with heart failure.

Implementation will depend on staffing, cost and local protocols. Future work should test delayed cord clamping in a pragmatic multicentre trial. Residual confounding cannot be excluded. These findings suggest that delayed cord clamping is associated with better ventilator-free days in patients with heart failure.

Future work should test delayed cord clamping in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols.

Strengths include the sample size and blinded outcome assessment. Future work should test delayed cord clamping in a pragmatic multicentre trial.

Conclusions

Delayed cord clamping should be considered for patients with heart failure to improve ventilator-free days.

References

1. Lindqvist J, Andersen O, et al. Machine-learning triage and chronic pain scores. JAMA. 2011;250(1):775-1106.

2. Yilmaz F, Mueller W, et al. SGLT2 inhibitors and ventilator-free days. Eur Heart J. 2018;256(5):334-1797.

3. Herrera O, Okafor Z, et al. Low-dose aspirin and chronic pain scores. Lancet. 2012;360(10):863-1103.

4. Rossi C, Farouk G, et al. Home-based cardiac rehabilitation and glycaemic control. Ann Intern Med. 2023;399(10):587-1660.

5. Zhang X, Farouk I, et al. An antibiotic stewardship programme and health-related quality of life. Crit Care Med. 2018;329(6):566-1665.

6. Yilmaz V, Haddad I, et al. Machine-learning triage and 30-day readmission. Pediatrics. 2021;338(5):577-1792.

7. Rahman T, Silva R, et al. Tranexamic acid and glycaemic control. BMJ. 2013;347(4):680-1282.

8. Herrera E, Novak C, et al. Frailty screening and length of stay. BMC Med. 2020;318(10):247-1337.

Appendices

Ethics approval: IRB-7269.

Materials and Methods

Missing data were handled with multiple imputation. We conducted a retrospective cohort study across 14 centres between 2016 and 2024. We conducted a retrospective cohort study across 11 centres between 2020 and 2023. We conducted a retrospective cohort study across 5 centres between 2017 and 2024.

We conducted a retrospective cohort study across 9 centres between 2016 and 2022. Missing data were handled with multiple imputation.

Results

1329 participants were included (median age 63 years). Serious adverse events were rare and similar between groups. 3945 participants were included (median age 31 years).

GroupnEvents
Age ≥ 6570860
Centre A1102
Intervention38385
Age < 6514723
Female29835
TABLE 1: Primary outcome by group
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Change in ventilator-free days
Shown for patients with heart failure; error bars are 95% confidence intervals.

Effects were consistent across prespecified subgroups. 2647 participants were included (median age 58 years). ventilator-free days occurred in 16% of the intervention group versus 13% of controls.